Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

Pan-Asia Catalysts/Events

Quiddity Advisors

Event-Driven

<ul>
<li>Aged care provider <a href="https://www.smartkarma.com/entities/estia-health-ltd" target="_blank" data-smartkarma-citation="entities:77:1" rel="noopener">Estia Health (EHE AU)</a> has appointed UBS to advise on Bain Capital's $3.00/share non-binding proposal.</li>
<li>The indicative  Offer arrives a little over two months after Kerry Stokes-backed <a href="https://www.smartkarma.com/entities/seven-group-holdings-ltd" target="_blank" data-smartkarma-citation="entities:803:1" rel="noopener">Seven Group Holdings (SVW AU)</a> off-loaded its 10% stake at ~ $2.00/share.</li>
<li>Separately, Regal Fund announced it has taken a 7% stake.</li>
</ul>


Aged care provider Estia Health (EHE AU) has appointed UBS to advise on Bain Capital's $3.00/share non-binding proposal.
The indicative  Offer arrives a little over two months after Kerry Stokes-backed Seven Group Holdings (SVW AU) off-loaded its 10% stake at ~ $2.00/share.
Separately, Regal Fund announced it has taken a 7% stake.


Estia Health: Bain's Non-Binding Proposal

IPOs and Catalysts/Events, Global Equity Research Ltd

Arun George

IPOs and Catalysts/Events

Uncompromised, Independent, Conflict-Free Research

Global Equity Research Ltd

Global Equity Research was started in 2017 by a group of experienced research professionals. It was founded on a passionate belief in the importance and the need for uncompromised, independent, conflict-free research. We aim to provide differentiated and actionable primary and bottom up fundamental research.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/estia-health-ltd" target="_blank" data-smartkarma-citation="entities:77:1" rel="noopener">Estia Health (EHE AU)</a> confirmed it has received a non-binding indicative proposal from Bain Capital at A$3.00 per share, a 28.2% premium to the undisturbed price (23 March).</li>
<li>The offer is attractive in comparison to historical share prices and multiples and implies a premium to <a href="https://www.smartkarma.com/entities/regis-healthcare-ltd" target="_blank" data-smartkarma-citation="entities:2086:1" rel="noopener">Regis Healthcare (REG AU)</a>’s (the key peer) multiples.  </li>
<li>However, the offer is light in comparison to precedent transactions multiples. The largest shareholder has also suggested the terms are light, which suggests a requirement for a bump.</li>
</ul>



Estia Health (EHE AU) confirmed it has received a non-binding indicative proposal from Bain Capital at A$3.00 per share, a 28.2% premium to the undisturbed price (23 March).
The offer is attractive in comparison to historical share prices and multiples and implies a premium to Regis Healthcare (REG AU)’s (the key peer) multiples.  
However, the offer is light in comparison to precedent transactions multiples. The largest shareholder has also suggested the terms are light, which suggests a requirement for a bump.


Estia Health (EHE AU): Bain Capital’s A$3.00 Offer

<ul>
<li>In <a href="https://skr.ma/83DEG" target="_blank" rel="noopener">Chip Eng Seng: Low-Balled MBO At $0.72/Share</a>, I thought there was scope for a bump. But then the Tang family bought a 9.02% stake on market.</li>
<li>The Tangs have now bumped the Offer Price for <a href="https://www.smartkarma.com/entities/chip-eng-seng-corp-ltd" target="_blank" data-smartkarma-citation="entities:6441:1" rel="noopener">Chip Eng Seng Corp (CHIP SP)</a> to S$0.75/share, up from S$0.72/share, and declared the terms final.</li>
<li>The Offer remains conditional on a 50% acceptance hurdle. With 47.27% in the bag, this is done.</li>
</ul>


In Chip Eng Seng: Low-Balled MBO At $0.72/Share, I thought there was scope for a bump. But then the Tang family bought a 9.02% stake on market.
The Tangs have now bumped the Offer Price for Chip Eng Seng Corp (CHIP SP) to S$0.75/share, up from S$0.72/share, and declared the terms final.
The Offer remains conditional on a 50% acceptance hurdle. With 47.27% in the bag, this is done.


Offer Price for Chip Eng Seng Bumped And Declared Final

<ul>
<li>Conglomerate<a href="https://www.smartkarma.com/entities/chip-eng-seng-corp-ltd" target="_blank" data-smartkarma-citation="entities:6441:1" rel="noopener"> Chip Eng Seng Corp (CHIP SP)</a> (CES) has announced a voluntary Offer of S$0.72/share from a Tang family-owned entity. The price is a 1.4% premium to last close.</li>
<li>The Tang's hold 38.23% and the Offer is conditional on a 50% acceptance condition. </li>
<li>The Offer price is a 27.3% discount to CES' NAV as of 30 June 2022 - no such mention in the announcement. The Offer price has not been declared final.</li>
</ul>


Conglomerate Chip Eng Seng Corp (CHIP SP) (CES) has announced a voluntary Offer of S$0.72/share from a Tang family-owned entity. The price is a 1.4% premium to last close.
The Tang's hold 38.23% and the Offer is conditional on a 50% acceptance condition. 
The Offer price is a 27.3% discount to CES' NAV as of 30 June 2022 - no such mention in the announcement. The Offer price has not been declared final.


Chip Eng Seng: Low-Balled MBO At $0.72/Share

<ul>
<li>After the Supreme Court of NSW ruled that <a href="https://www.smartkarma.com/entities/perpetual-ltd" target="_blank" data-smartkarma-citation="entities:599:1" rel="noopener">Perpetual Ltd (PPT AU)</a> cannot stall the Scheme for <a href="https://www.smartkarma.com/entities/pendal-group-ltd" target="_blank" data-smartkarma-citation="entities:15795:1" rel="noopener">Pendal Group (PDL AU)</a>, the Scheme Booklet is now <a href="https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02601374-2A1415198?access_token=83ff96335c2d45a094df02a206a39ff4" target="_blank" rel="noopener">out</a>.  </li>
<li>Under the revised terms, Pendal shareholders will receive 1 Perpetual (share for every 7 Pendal shares plus $1.65/share cash. The IE concluded the terms are fair and reasonable. </li>
<li>The Scheme Meeting will be held on the 23 December, with an expected implementation date on the 23 January.</li>
</ul>


After the Supreme Court of NSW ruled that Perpetual Ltd (PPT AU) cannot stall the Scheme for Pendal Group (PDL AU), the Scheme Booklet is now out.  
Under the revised terms, Pendal shareholders will receive 1 Perpetual (share for every 7 Pendal shares plus $1.65/share cash. The IE concluded the terms are fair and reasonable. 
The Scheme Meeting will be held on the 23 December, with an expected implementation date on the 23 January.


Pendal/​Perpetual: 23 Dec Scheme Meeting

Australia

Japara Healthcare Limited, is a provider of aged care and retirement living services in Australia.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Japara Healthcare (JHC AU)

Estia Health: Bain's Non-Binding Proposal

The Offer price is not unreasonable. This is a non-binding situation - currently trading at a 13.9% gross spread. Get involved here and on any...

David Blennerhassett

Estia Health (EHE AU): Bain Capital’s A$3.00 Offer

The offer is attractive in comparison to historical and peer multiples but light in comparison to precedent transaction multiples. At the last...

Arun George

Offer Price for Chip Eng Seng Bumped And Declared Final

With just 2.73% of shares out required to tender to get this over the line, this appears done. Trading at a gross/annualised spread of 1.4%/10.7%...

David Blennerhassett

Pendal/Perpetual: 23 Dec Scheme Meeting

I'd still short Perpetual, Long Pendal. But I hear borrow is tight for PPT. I expect the Pendal deal to get up. Currently trading at a 9.3% gross...

David Blennerhassett

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Estia Health: Bain's Non-Binding Proposal

The Offer price is not unreasonable. This is a non-binding situation - currently trading at a 13.9% gross spread. Get involved here and on any...

David Blennerhassett

Estia Health (EHE AU): Bain Capital’s A$3.00 Offer

The offer is attractive in comparison to historical and peer multiples but light in comparison to precedent transaction multiples. At the last...

Arun George

Offer Price for Chip Eng Seng Bumped And Declared Final

With just 2.73% of shares out required to tender to get this over the line, this appears done. Trading at a gross/annualised spread of 1.4%/10.7%...

David Blennerhassett

Chip Eng Seng: Low-Balled MBO At $0.72/Share

There is scope for a bump here. This Offer is less of a certainty that the Singhaiyi transaction. Get involved here or a spread (or two) below terms.

David Blennerhassett

Pendal/​Perpetual: 23 Dec Scheme Meeting

I'd still short Perpetual, Long Pendal. But I hear borrow is tight for PPT. I expect the Pendal deal to get up. Currently trading at a 9.3% gross...

David Blennerhassett

Pendal/Perpetual: 23 Dec Scheme Meeting